Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$334000.0.

  • Maravai Lifesciences Holdings' Gains from Investment Securities fell 6700.0% to -$334000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.2 million, marking a year-over-year decrease of 10074.17%. This contributed to the annual value of -$2.0 million for FY2024, which is 10609.52% down from last year.
  • Maravai Lifesciences Holdings' Gains from Investment Securities amounted to -$334000.0 in Q3 2025, which was down 6700.0% from $140000.0 recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Gains from Investment Securities registered a high of $22.6 million during Q4 2021, and its lowest value of -$7.8 million during Q1 2022.
  • For the 5-year period, Maravai Lifesciences Holdings' Gains from Investment Securities averaged around $1.9 million, with its median value being -$30000.0 (2024).
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Gains from Investment Securities skyrocketed by 220111.32% in 2021, and later plummeted by 270000.0% in 2022.
  • Over the past 5 years, Maravai Lifesciences Holdings' Gains from Investment Securities (Quarter) stood at $22.6 million in 2021, then crashed by 84.76% to $3.5 million in 2022, then tumbled by 30.89% to $2.4 million in 2023, then plummeted by 237.95% to -$3.3 million in 2024, then soared by 89.85% to -$334000.0 in 2025.
  • Its Gains from Investment Securities stands at -$334000.0 for Q3 2025, versus $140000.0 for Q2 2025 and $236000.0 for Q1 2025.